Disulfiram, a clinically employed alcohol deterrent, was recently discovere
d to inhibit caspase-3 and DNA fragmentation. Using LLC-PK1 cells and murin
e liver as models, we examined if the drug inhibited TNF-alpha-induced cell
death. Disulfiram produced dose-dependent inhibition of TNF-alpha-induced
cell death as well as caspase-3-like activity, Disulfiram retained 80% of i
ts effect when added 4 h after TNF-alpha. Disulfiram protected the cells fr
om cytokine-induced death for at least 6 days. The cells rescued by the dru
g preserved the ability to proliferate. The cells died spontaneously after
exposure to TNF-alpha for just 70 min. Co-administration of 15 mu M disulfi
ram and TNF-alpha for 70 min prior to their removal abolished TNF-alpha-ind
uced killing, and this was associated with restoration of mitochondrial mem
brane potential and suppression of reactive oxygen species. Treatment of mi
ce with TNF-alpha and D-galactosamine for 5 h markedly increased hepatic DN
A fragmentation and caspase-3-like activity. Disulfiram at 0.6 mmol/kg abol
ished these effects. We conclude that disulfiram is a potent inhibitor of T
NF-alpha-induced cell death in vitro. The underlying mechanisms include sta
bilization of mitochondrial membrane potential, suppression of reactive oxy
gen species, and inhibition of caspase-3-like activity. We further conclude
that disulfiram inhibits DNA fragmentation in vivo in association with the
blockade of caspase-3-like activity.